Vascular lesion laser market to reach $3.04 billion by 2030

The vascular lesion treatment laser market is projected to grow from $1.83 billion in 2025 to $3.04 billion by 2030, driven by demand for minimally invasive and cosmetic dermatology procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Vascular lesion treatment lasers are gaining traction because they support less invasive care with faster recovery and minimal scarring. - The market outlook signals continued demand in cosmetic dermatology, outpatient treatment, and pediatric vascular care. - The report points to a broader shift toward clinic-based procedures that avoid traditional surgery.

What happened: - The Business Research Company published a report on the global vascular lesion treatment laser market on September 3, 2026. - The market is expected to increase from $1.83 billion in 2025 to $2.03 billion in 2026. - The report projects the market will reach $3.04 billion by 2030. - The forecast implies a 10.9% CAGR from 2025 to 2026 and a 10.7% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - Vascular lesion treatment lasers are medical devices used to target abnormal blood vessels such as spider veins, hemangiomas and port-wine stains. - The devices work by emitting focused light energy that heats and collapses vessels without damaging surrounding skin tissue. - The report ties historical growth to rising vascular conditions, stronger clinical evidence, laser technology advances, outpatient care preferences and cosmetic dermatology demand. - Future growth is linked to more aesthetic procedures, expansion in pediatric dermatology, laser system innovation, clinic-based treatment demand and an aging population. - Key trends include non-invasive aesthetic therapy, scar-free interventions, pediatric vascular treatments and outpatient laser procedures. - Minimally invasive procedures are helping drive adoption because they reduce tissue trauma, pain, complications and recovery time. - Data from the American Society of Plastic Surgeons released in June 2024 showed minimally invasive procedures rose 7% in 2023, outpacing traditional surgery by 2%. - The report says vascular lesion treatment lasers complement minimally invasive care by precisely targeting blood vessels while limiting damage to nearby tissue. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis.

Between the lines: - The market forecast suggests aesthetic medicine and therapeutic dermatology are converging around the same technology platform. - North America’s lead points to a mature adoption base, while faster growth in Asia-Pacific suggests room for broader procedure uptake and new clinic expansion. - The emphasis on outpatient and clinic-based treatment reflects pressure to reduce cost and inconvenience versus surgical alternatives.

What's next: - The market is expected to keep expanding through 2030 as non-invasive and minimally invasive procedures gain share. - Pediatric use, aesthetic applications and outpatient adoption are likely to remain the main demand drivers. - The report positions new forecasting tools and regional analysis as resources for companies tracking growth opportunities and competitive positioning.

The bottom line: - Vascular lesion treatment lasers are moving from a niche specialty device category into a broader growth market built on patient preference for faster, cleaner and less invasive treatment.